Vijay Pande, founding partner of a16z bio and health strategy, steps down

Vijay Pande, a basic associate at Andreessen Horowitz who based the agency’s a16z Bio+ Well being technique, announced that he’s stepping down from his position.

Since its founding in 2014, a16z Bio+ Well being has raised 4 funds of practically $3 billion every, together with a $1.5 billion fund that closed in 2022. Nevertheless, it’s now in search of a a lot smaller $750 million fifth fund, The Wall Road Journal reported. In January, a16z Bio+ Well being introduced that it’s going to handle a $500 million biotech fund funded by pharmaceutical large Eli Lilly.

a16z Bio + Well being backs digital well being startups and corporations on the intersection of AI, computation, and biology.

Pande’s investments embody Devoted Well being, an individualized medical plan supplier; Perform Well being, a personalised lab testing startup; and Freenome, an organization aiming to detect most cancers by way of blood attracts. Earlier than becoming a member of Andreessen Horowitz, Pande was a professor of chemistry, structural biology, and laptop science at Stanford College.

The remaining companions on the a16z Bio + Well being group are Jorge Conde, Julie Yoo, and Vineeta Agarwala.